Actin-Binding rho Activating Protein (ABRA) (Middle Region) Peptide
ABRA
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN972767
Quick Overview for Actin-Binding rho Activating Protein (ABRA) (Middle Region) Peptide (ABIN972767)
Target
ABRA
(Actin-Binding rho Activating Protein (ABRA))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequence
- QWADEHIQSQ KLNPFSEEFD YELAMSTRLH KGDEGYGRPK EGTKTAERAK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ABRA Antibody(ARP52674_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Background
-
ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling.
Alias Symbols: STARS
Protein Interaction Partner: ACTB,ACTC1
Protein Size: 381 -
Molecular Weight
- 43 kDa
-
Gene ID
- 137735
-
NCBI Accession
- NM_139166, NP_631905
-
UniProt
- Q8N0Z2
Target
-
You are here:
